Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese Törngren, Anders Kvist, Markus Ringnér, Inge Marie Svane and Göran Jönsson ()
Additional contact information
Martin Lauss: Lund University
Marco Donia: Center for Cancer Immune Therapy, Department of Hematology
Katja Harbst: Lund University
Rikke Andersen: Center for Cancer Immune Therapy, Department of Hematology
Shamik Mitra: Lund University
Frida Rosengren: Lund University
Maryem Salim: Lund University
Johan Vallon-Christersson: Lund University
Therese Törngren: Lund University
Anders Kvist: Lund University
Markus Ringnér: Lund University
Inge Marie Svane: Center for Cancer Immune Therapy, Department of Hematology
Göran Jönsson: Lund University

Nature Communications, 2020, vol. 11, issue 1, 1-1

Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-020-15531-2 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15531-2

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-020-15531-2

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().